Sodium;ethyl 2-bromoacetate;ethyl 2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetate;7-methoxy-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;7-methoxy-5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepine;5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-ol;2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetic acid;hydroxide
C115H123BrF12N5NaO12S4 — CID 157370789
Data last refreshed: (MolForge compound catalog, from PubChem)
About Sodium;ethyl 2-bromoacetate;ethyl 2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetate;7-methoxy-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;7-methoxy-5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepine;5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-ol;2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetic acid;hydroxide
Sodium;ethyl 2-bromoacetate;ethyl 2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetate;7-methoxy-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;7-methoxy-5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepine;5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-ol;2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetic acid;hydroxide (PubChem CID 157370789) has the molecular formula C115H123BrF12N5NaO12S4 and a molecular weight of 2226.41 g/mol. Its IUPAC name is sodium;ethyl 2-bromoacetate;ethyl 2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetate;7-methoxy-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;7-methoxy-5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepine;5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-ol;2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetic acid;hydroxide.
Molecular Properties
| Compound Name | Sodium;ethyl 2-bromoacetate;ethyl 2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetate;7-methoxy-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;7-methoxy-5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepine;5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-ol;2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetic acid;hydroxide |
|---|---|
| PubChem CID | 157370789 |
| Molecular Formula | C115H123BrF12N5NaO12S4 |
| Molecular Weight | 2226.41 g/mol |
| Exact Mass | 2223.69 |
| IUPAC Name | sodium;ethyl 2-bromoacetate;ethyl 2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetate;7-methoxy-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;7-methoxy-5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepine;5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-ol;2-[[5-methyl-3-[[5-[4-(trifluoromethyl)phenyl]thiophen-2-yl]methyl]-1,2,4,5-tetrahydro-3-benzazepin-7-yl]oxy]acetic acid;hydroxide |
| SMILES | CC1CN(Cc2ccc(-c3ccc(C(F)(F)F)cc3)s2)CCc2ccc(O)cc21.CC1CN(Cc2ccc(-c3ccc(C(F)(F)F)cc3)s2)CCc2ccc(OCC(=O)O)cc21.CCOC(=O)CBr.CCOC(=O)COc1ccc2c(c1)C(C)CN(Cc1ccc(-c3ccc(C(F)(F)F)cc3)s1)CC2.COc1ccc2c(c1)C(C)CN(Cc1ccc(-c3ccc(C(F)(F)F)cc3)s1)CC2.COc1ccc2c(c1)C(C)CNCC2.[Na+].[OH-] |
| InChI | InChI=1S/C27H28F3NO3S.C25H24F3NO3S.C24H24F3NOS.C23H22F3NOS.C12H17NO.C4H7BrO2.Na.H2O/c1-3-33-26(32)17-34-22-9-6-19-12-13-31(15-18(2)24(19)14-22)16-23-10-11-25(35-23)20-4-7-21(8-5-20)27(28,29)30;1-16-13-29(11-10-17-4-7-20(12-22(16)17)32-15-24(30)31)14-21-8-9-23(33-21)18-2-5-19(6-3-18)25(26,27)28;1-16-14-28(12-11-17-5-8-20(29-2)13-22(16)17)15-21-9-10-23(30-21)18-3-6-19(7-4-18)24(25,26)27;1-15-13-27(11-10-16-4-7-19(28)12-21(15)16)14-20-8-9-22(29-20)17-2-5-18(6-3-17)23(24,25)26;1-9-8-13-6-5-10-3-4-11(14-2)7-12(9)10;1-2-7-4(6)3-5;;/h4-11,14,18H,3,12-13,15-17H2,1-2H3;2-9,12,16H,10-11,13-15H2,1H3,(H,30,31);3-10,13,16H,11-12,14-15H2,1-2H3;2-9,12,15,28H,10-11,13-14H2,1H3;3-4,7,9,13H,5-6,8H2,1-2H3;2-3H2,1H3;;1H2/q;;;;;;+1;/p-1 |
| InChIKey | BJSSTOYZXIZRKI-UHFFFAOYSA-M |
| XLogP | 25.22 |
| TPSA | 202.04 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 150 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2226.41 |
| LogP ≤ 5 | 25.22 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 20 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157370789 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.